| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Staphylococcus aureus (OC4172) |
- |
- |
8 － ? |
4-phenylpiperidine  |
673 |
| Staphylococcus aureus (OC4172) |
- |
- |
32 － ? |
Cycloserine (Seromycin) |
673 |
| Staphylococcus aureus (OC667 + methicillin-resistant) |
- |
- |
2 － ? |
RWJ-49619 |
132 |
| Staphylococcus aureus (OC667 + methicillin-resistant) |
- |
- |
2 － ? |
RWJ-49640 |
132 |
| Staphylococcus aureus (OC667 + methicillin-resistant) |
- |
- |
2 － ? |
RWJ-49815 |
132 |
| Staphylococcus aureus (OC667 + methicillin-resistant) |
- |
- |
>32 － ? |
RWJ-60953 |
132 |
| Staphylococcus aureus (OC667) |
- |
- |
0.5 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
132 |
| Staphylococcus aureus (OC667) |
- |
- |
4 － ? |
RWJ-49815 |
132 |
| Staphylococcus aureus (OF4 + methicillin-resistant) |
- |
- |
1.56 － ? |
FNQ13 |
257 |
| Staphylococcus aureus (ofloxacin-resistant + methicillin-resistant) |
4 |
8 |
1 － 64 |
Moxifloxacin (BAY 12-8039, Avelox) |
130 |
| Staphylococcus aureus (ofloxacin-susceptible + methicillin-resistant) |
0.12 |
0.12 |
0.03 － 0.25 |
Moxifloxacin (BAY 12-8039, Avelox) |
130 |
| Staphylococcus aureus (OK1) |
- |
- |
125 － ? |
Ziziphus mucronata subsp. mucronata (Ethanol extract) |
1546 |
| Staphylococcus aureus (OK3) |
- |
- |
187.5 － ? |
Ziziphus mucronata subsp. mucronata (Ethanol extract) |
1546 |
| Staphylococcus aureus (OKOH1) |
- |
- |
1 － ? |
Amoxicillin (Novamox, Amoxil) |
1302 |
| Staphylococcus aureus (OKOH1) |
- |
- |
1 － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
1302 |
| Staphylococcus aureus (OKOH1) |
- |
- |
1 － ? |
Erythromycin (E-mycin, Ery-tab, Benzamycin) |
1302 |
| Staphylococcus aureus (OKOH1) |
- |
- |
1 － ? |
Oxytetracycline (Terramycin, Oxitetracycline) |
1302 |
| Staphylococcus aureus (OKOH1) |
- |
- |
1 － ? |
Sodium Penicillin |
1302 |
| Staphylococcus aureus (OKOH1) |
- |
- |
4 － ? |
Chloramphenicol (Chloromycetin) |
1302 |
| Staphylococcus aureus (OKOH1) |
- |
- |
1000 － ? |
Helichrysum longifolium (Methanol extract) |
1302 |
| Staphylococcus aureus (OKOH1) |
- |
- |
5000 － ? |
Helichrysum longifolium (Acetone extract) |
1302 |
| Staphylococcus aureus (oxacillin-resistant + levofloxacin-resistant) |
0.25 |
0.5 |
0.25 － 1 |
PD 0305970 |
225 |
| Staphylococcus aureus (oxacillin-resistant + levofloxacin-resistant) |
1 |
4 |
0.25 － 4 |
PD 0326448 |
225 |
| Staphylococcus aureus (oxacillin-resistant + levofloxacin-resistant) |
2 |
4 |
0.25 － 32 |
Garenoxacin (T-3811, BMS-284756) |
225 |
| Staphylococcus aureus (oxacillin-resistant + levofloxacin-resistant) |
8 |
16 |
1 － 64 |
Gatifloxacin (Tequin) |
225 |
| Staphylococcus aureus (oxacillin-resistant + levofloxacin-resistant) |
32 |
64 |
16 － >64 |
Levofloxacin (Levaquin, Quixin) |
225 |
| Staphylococcus aureus (oxacillin-resistant) |
>0.05 |
>4 |
? － ? |
Doxycycline (Doxycycline hyclate, Doxy, Vibra, Vibramycin) |
39 |
| Staphylococcus aureus (oxacillin-resistant) |
0.06 |
0.12 |
≤0.03 － 0.12 |
Retapamulin |
592 |